循证医学在指导制订全髋关节置换术红细胞用血计划中的应用  

The application of evidence-based medicine in guiding planning usage plan of red blood cells in total hip arthroplasty

作　　者：孙福廷[1] 冀宝军[1] 王立萍[1] 

机构地区：[1]潍坊市人民医院输血科,山东潍坊261041

出　　处：《医学检验与临床》2017年第5期35-36,24,共3页Medical Laboratory Science and Clinics

摘　　要：目的：用循证医学方法为临床科学制订全髋关节置换术红细胞用血计划提供实验室依据.方法：统计2011年~2013年本院全髋关节置换术红细胞计划用量和术中实际用量及两者差异,计算每年全髋关节置换术红细胞用量及年间差异.结果：股骨头缺血性坏死、 股骨颈骨折、 其他髋关节病变致全髋关节置换术前红细胞计划用量（U）分别为2.97±1.01、3.26±0.99、3.16±1.07,术中实际用量（U）分别为4.77±2.33、5.42±3.91、6.08±4.80,计划量与实际使用量比较P值分别为0.00、0.02、0.0,差异有统计学意义;2011年~2013年三年间全髋关节置换术中实际红细胞用量（U）分别为5.22±3.01、5.11±3.90、5.00±3.80,每年略有下降,但P值为0.96,差异无统计学意义,三年平均用量（U）为5.11±3.57.结论：循证医学方法具有客观性,分析术中实际用血量从而指导制订同类手术用血计划具有实际意义,用血计划影响血液库存量.Objective： To provide laboratory evidence by using Evidence-based medicine in making reasonable usage plan of Pd3C on total hip arthroplasty. Methods： The Statistical analysis method was used to compare the differences between preoperative planning quantity and intraoperadve using quantity of RBC in total hip arthroplasty. And the actual usage of each year was calculated and compared. Results： The usage plan of R.BC on avascular necrosis of femoral head, femoral neck fracture and other hip lesions induced total hip arthroplasty was 2.97±1.01, 3.26±0.99, 3.16±1.07 and the actual？ usage ofP, BC was 4.77±2.33, 5.42±3.91, 6.08±4.80, P value is 0.00, 0.02, 0.0 respectively, the difference is statistically significant. In 2011-2013, annual usage of RBC on total hip arthroplasty was 5.22±3.01, 5.11± 3.90, 5.00±3.80, there is no stadstica/ly significant difference （P=0.96） . The average usage （tO was 5.11 ± 3.57. Conclusion： Evidence- based medicine is objective. We can analyze actual amount o^tLBC to direct usage plan ofP, BC. Usage plan of Blood can influence blood inventory level.

关 键 词：循证医学 全髋关节置换术 用血计划 

分 类 号：R687.4[医药卫生—骨科学]